JKJia Ke

Jia Ke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jia Ke has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Bingjian Wang

    State Key Laboratory of Medicinal Chemical Biology College of Pharmacy Nankai University 38 Tongyan Rd Tianjin 300350 China

    2 shared publications
  • Chuanke Chong

    State Key Laboratory of Medicinal Chemical Biology College of Pharmacy Nankai University 38 Tongyan Rd Tianjin 300350 China

    2 shared publications
  • Haiming Zhang

    State Key Laboratory of Medicinal Chemical Biology College of Pharmacy Nankai University 38 Tongyan Rd Tianjin 300350 China

    2 shared publications
  • Qunlong Zhang

    State Key Laboratory of Medicinal Chemical Biology College of Pharmacy Nankai University 38 Tongyan Rd Tianjin 300350 China

    2 shared publications
  • Wei Ding

    Tianjin Key Laboratory of Human Development and Reproductive Regulation Tianjin Central Hospital of Gynecology Obstetrics Nankai University 156 Third Rd Tianjin 300052 China

    2 shared publications
  • Xudong Yang

    State Key Laboratory of Medicinal Chemical Biology College of Pharmacy Nankai University 38 Tongyan Rd Tianjin 300350 China

    2 shared publications

Latest Publications

  • Total Synthesis of Anti‐Cancer Meroterpenoids Dysideanone B and Dysiherbol A and Structural Reassignment of Dysiherbol A

    by Chuanke Chong, Qunlong Zhang, Jia Ke, Haiming Zhang, Xudong Yang, Bingjian Wang, Wei Ding, Zhaoyong Lu

    The first total synthesis of marine anti‐cancer meroterpenoids dysideanone B and dysiherbol A have been accomplished in a divergent way. The synthetic route features: 1) a site and stereoselective α‐position alkylation of a Wieland–Miescher ketone derivative with a bulky benzyl bromide to join the terpene and aromatic moieties together and set the stage for subsequent cyclization reactions; 2) an intramolecular radical cyclization to construct the 6/6/6/6‐tetracycle of dysideanone B and an intramolecular Heck reaction to forge the 6/6/5/6‐fused core structure of dysiherbol A. A late‐stage introduction of the ethoxy group in dysideanone B reveals that this group might come from the solvent ethanol. The structure of dysiherbol A has been revised based on our chemical total synthesis.


  • Total Synthesis of Anti‐Cancer Meroterpenoids Dysideanone B and Dysiherbol A and Structural Reassignment of Dysiherbol A

    by Chuanke Chong, Qunlong Zhang, Jia Ke, Haiming Zhang, Xudong Yang, Bingjian Wang, Wei Ding, Zhaoyong Lu

    The first total synthesis of marine anti‐cancer meroterpenoids dysideanone B and dysiherbol A have been accomplished in a divergent way. The synthetic route features: 1) a site and stereoselective α‐position alkylation of a Wieland–Miescher ketone derivative with a bulky benzyl bromide to join the terpene and aromatic moieties together and set the stage for subsequent cyclization reactions; 2) an intramolecular radical cyclization to construct the 6/6/6/6‐tetracycle of dysideanone B and an intramolecular Heck reaction to forge the 6/6/5/6‐fused core structure of dysiherbol A. A late‐stage introduction of the ethoxy group in dysideanone B reveals that this group might come from the solvent ethanol. The structure of dysiherbol A has been revised based on our chemical total synthesis.